- Home
- GRDN vs BXMX Comparison
GRDN vs BXMX Comparison
Compare GRDN & BXMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRDN
- BXMX
- Stock Information
- Founded
- GRDN 2004
- BXMX 2004
- Country
- GRDN United States
- BXMX United States
- Employees
- GRDN N/A
- BXMX N/A
- Industry
- GRDN Retail-Drug Stores and Proprietary Stores
- BXMX Investment Managers
- Sector
- GRDN Consumer Staples
- BXMX Finance
- Exchange
- GRDN Nasdaq
- BXMX Nasdaq
- Market Cap
- GRDN 1.7B
- BXMX 1.5B
- IPO Year
- GRDN 2024
- BXMX N/A
- Fundamental
- Price
- GRDN $31.52
- BXMX $14.46
- Analyst Decision
- GRDN Strong Buy
- BXMX
- Analyst Count
- GRDN 2
- BXMX 0
- Target Price
- GRDN $30.00
- BXMX N/A
- AVG Volume (30 Days)
- GRDN 345.1K
- BXMX 205.6K
- Earning Date
- GRDN 11-10-2025
- BXMX 01-01-0001
- Dividend Yield
- GRDN N/A
- BXMX 7.24%
- EPS Growth
- GRDN N/A
- BXMX N/A
- EPS
- GRDN 0.64
- BXMX N/A
- Revenue
- GRDN $1,389,638,000.00
- BXMX N/A
- Revenue This Year
- GRDN $16.33
- BXMX N/A
- Revenue Next Year
- GRDN $2.10
- BXMX N/A
- P/E Ratio
- GRDN $49.27
- BXMX N/A
- Revenue Growth
- GRDN 18.68
- BXMX N/A
- 52 Week Low
- GRDN $17.78
- BXMX $11.75
- 52 Week High
- GRDN $37.43
- BXMX $13.75
- Technical
- Relative Strength Index (RSI)
- GRDN 75.47
- BXMX 54.18
- Support Level
- GRDN $27.39
- BXMX $14.18
- Resistance Level
- GRDN $37.43
- BXMX $14.52
- Average True Range (ATR)
- GRDN 1.63
- BXMX 0.14
- MACD
- GRDN 0.27
- BXMX -0.01
- Stochastic Oscillator
- GRDN 42.21
- BXMX 63.97
About GRDN Guardian Pharmacy Services Inc. Class A Common Stock
Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.
About BXMX Nuveen S&P 500 Buy-Write Income Fund of Beneficial Interest
Nuveen S&P 500 Buy-Write Income Fund is a diversified closed-ended management investment company based in the United States. Its investment objective is to seek attractive total returns with less volatility. The fund invests its managed assets in a diversified equity portfolio that seeks to substantially replicate price movements of the S&P 500 Index. It also uses an index options of writing (selling) index call options in seeking to moderate the volatility of returns relative to an all-equity portfolio. Its revenue is generated mainly from interest and dividend income.